2McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alpha2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Eng J Med, 1998,339:1485-1492.
3Zeuzem S. Clinical implications of hepatitis C viral kinetics. J Hepatol, 1999, 31(Suppl) :61-64.
4Neumann AU, Lam NP, Dahari H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-α therapy.Science, 1998, 282:103-107.
5Wang YS, Youngster S, Bausch J, et al . Identification of the major positional isomer of pegylated interferon alpha-2b. Biochemistry, 2000, 39:10634-10640.
6Monkarsh SP, Ma Y, Aglione A, et al. Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity. Anal Biochem, 1997: 247:434-440.
7Heathcote EJ, Shiftman ML, Cooksley WG, et al. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Eng J Med, 2000,343:1673-1680.
